Clinical Trials Directory

Trials / Completed

CompletedNCT01277159

Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Hospital for Special Surgery, New York · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Patients scheduled to go home after ankle surgery at HSS typically receive a sciatic nerve block in the popliteal fossa and oral analgesic tablets (such as Percocet). Popliteal fossa nerve blockade has reduced pain for these patients (YaDeau et al, Anesth Analg 2008;106:1916-20), but unfortunately the patients still often experience moderate to severe pain after the block wears off. The investigators wish to study two additives that may prolong the period of analgesia provided by the nerve block. The additives will be studied in the context of a standardized postoperative multimodal analgesic pathway. Primary outcome: Does adding dexamethasone and / or buprenorphine prolong the analgesia provided by a popliteal fossa nerve block?

Conditions

Interventions

TypeNameDescription
DRUGA. Control Nerve Block. IV Dexamethasone (4 mg).A. Control Nerve Block. IV Dexamethasone (4 mg).
DRUGB. Nerve Block with Dexamethasone (4 mg). IV saline.B. Nerve Block with Dexamethasone (4 mg). IV saline.
DRUGC. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg)C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg)
DRUGD. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).
DRUGE. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg).E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg). IV saline.

Timeline

Start date
2010-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-01-14
Last updated
2022-04-14
Results posted
2017-08-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01277159. Inclusion in this directory is not an endorsement.